NCT04953065View on ClinicalTrials.gov

Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

August 30, 2021

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Malignancies Multiple
Interventions
OTHER

COVID-19 vaccine hesitancy and acceptance survey

Participants will be provided with a COVID-19 vaccine hesitancy and acceptance survey developed by the study team.

Trial Locations (1)

17033

Penn State Cancer Institute, Hershey

All Listed Sponsors
lead

Monika Joshi

OTHER

NCT04953065 - Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients | Biotech Hunter | Biotech Hunter